Clinical Trial Update: Long-term Safety of UC-MSC Transplantation in Patients With Retinitis Pigmentosa

View source ↗

Summary

This clinical trial update describes a study assessing the long-term safety of umbilical cord-derived mesenchymal stem cell (UC-MSC) transplantation in Retiniti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retinitis Pigmentosa

Drugs mentioned

• UC-MSC transplantation (umbilical cord mesenchymal stem cells) (umbilical cord mesenchymal stem cells)

Snippet

Sponsor: PT. Prodia Stem Cell Indonesia | Conditions: Retinitis Pigmentosa | Status: NOT_YET_RECRUITING